These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 11128812

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma--a feasibility study.
    Reichardt VL, Okada CY, Liso A, Benike CJ, Stockerl-Goldstein KE, Engleman EG, Blume KG, Levy R.
    Blood; 1999 Apr 01; 93(7):2411-9. PubMed ID: 10090953
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides.
    Curti A, Tosi P, Comoli P, Terragna C, Ferri E, Cellini C, Massaia M, D'Addio A, Giudice V, Di Bello C, Cavo M, Conte R, Gugliotta G, Baccarani M, Lemoli RM.
    Br J Haematol; 2007 Nov 01; 139(3):415-24. PubMed ID: 17910631
    [Abstract] [Full Text] [Related]

  • 5. Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapy.
    Coscia M, Mariani S, Battaglio S, Di Bello C, Fiore F, Foglietta M, Pileri A, Boccadoro M, Massaia M.
    Leukemia; 2004 Jan 01; 18(1):139-45. PubMed ID: 14574332
    [Abstract] [Full Text] [Related]

  • 6. Induction of cellular immune responses in patients with stage-I multiple myeloma after vaccination with autologous idiotype-pulsed dendritic cells.
    Röllig C, Schmidt C, Bornhäuser M, Ehninger G, Schmitz M, Auffermann-Gretzinger S.
    J Immunother; 2011 Jan 01; 34(1):100-6. PubMed ID: 21150718
    [Abstract] [Full Text] [Related]

  • 7. Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cells.
    Reichardt VL, Milazzo C, Brugger W, Einsele H, Kanz L, Brossart P.
    Haematologica; 2003 Oct 01; 88(10):1139-49. PubMed ID: 14555310
    [Abstract] [Full Text] [Related]

  • 8. Idiotype protein-pulsed dendritic cells produce strong anti-myeloma effects after syngeneic stem cell transplantation in mice.
    Zeis M, Frenzke H, Schmitz N, Uharek L, Steinmann J.
    Bone Marrow Transplant; 2002 Feb 01; 29(3):213-21. PubMed ID: 11859393
    [Abstract] [Full Text] [Related]

  • 9. Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients.
    Timmerman JM, Czerwinski DK, Davis TA, Hsu FJ, Benike C, Hao ZM, Taidi B, Rajapaksa R, Caspar CB, Okada CY, van Beckhoven A, Liles TM, Engleman EG, Levy R.
    Blood; 2002 Mar 01; 99(5):1517-26. PubMed ID: 11861263
    [Abstract] [Full Text] [Related]

  • 10. Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects.
    Titzer S, Christensen O, Manzke O, Tesch H, Wolf J, Emmerich B, Carsten C, Diehl V, Bohlen H.
    Br J Haematol; 2000 Mar 01; 108(4):805-16. PubMed ID: 10792287
    [Abstract] [Full Text] [Related]

  • 11. Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation.
    Bendandi M, Rodríguez-Calvillo M, Inogés S, López-Díaz de Cerio A, Pérez-Simón JA, Rodríguez-Caballero A, García-Montero A, Almeida J, Zabalegui N, Giraldo P, San Miguel J, Orfao A.
    Leuk Lymphoma; 2006 Jan 01; 47(1):29-37. PubMed ID: 16321824
    [Abstract] [Full Text] [Related]

  • 12. Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy.
    Curti A, Isidori A, Ferri E, Terragna C, Neyroz P, Cellini C, Ratta M, Baccarani M, Lemoli RM.
    Leuk Lymphoma; 2004 Jul 01; 45(7):1419-28. PubMed ID: 15359643
    [Abstract] [Full Text] [Related]

  • 13. Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma.
    Lim SH, Bailey-Wood R.
    Int J Cancer; 1999 Oct 08; 83(2):215-22. PubMed ID: 10471530
    [Abstract] [Full Text] [Related]

  • 14. Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients.
    Yi Q, Szmania S, Freeman J, Qian J, Rosen NA, Viswamitra S, Cottler-Fox M, Barlogie B, Tricot G, van Rhee F.
    Br J Haematol; 2010 Sep 08; 150(5):554-64. PubMed ID: 20618329
    [Abstract] [Full Text] [Related]

  • 15. Idiotype vaccination following ABMT can stimulate specific anti-idiotype immune responses in patients with B-cell lymphoma.
    Davis TA, Hsu FJ, Caspar CB, van Beckhoven A, Czerwinsk DK, Liles TM, Taidi B, Benike CJ, Engleman EG, Levy R.
    Biol Blood Marrow Transplant; 2001 Sep 08; 7(9):517-22. PubMed ID: 11669219
    [Abstract] [Full Text] [Related]

  • 16. Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma.
    Hájek R, Butch AW.
    Med Oncol; 2000 Feb 08; 17(1):2-15. PubMed ID: 10713654
    [Abstract] [Full Text] [Related]

  • 17. Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patients.
    Hobo W, Strobbe L, Maas F, Fredrix H, Greupink-Draaisma A, Esendam B, de Witte T, Preijers F, Levenga H, van Rees B, Raymakers R, Schaap N, Dolstra H.
    Cancer Immunol Immunother; 2013 Aug 08; 62(8):1381-92. PubMed ID: 23728352
    [Abstract] [Full Text] [Related]

  • 18. [Induction of active antitumor immune response by myeloma idiotype protein-pulsed dendritic cells].
    Yin XR, Zhang M, Luo YY, Lin X, He PC, Chen LM, Cai RB, Guo GL.
    Ai Zheng; 2005 Jun 08; 24(6):657-62. PubMed ID: 15946473
    [Abstract] [Full Text] [Related]

  • 19. B-cell lymphoma and myeloma protection induced by idiotype vaccination with dendritic cells is mediated entirely by T cells in mice.
    Cohen S, Haimovich J, Hollander N.
    J Immunother; 2005 Jun 08; 28(5):461-6. PubMed ID: 16113602
    [Abstract] [Full Text] [Related]

  • 20. A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma.
    Qazilbash MH, Saini NY, Cha SC, Wang Z, Stadtmauer EA, Baladandayuthapani V, Lin H, Tross B, Honhar M, Rao SS, Kim K, Popescu M, Szymura S, Zhang T, Anderson A, Bashir Q, Shpall EJ, Orlowski RZ, Levine BL, Kerr N, Garfall A, Cohen A, Vogl DT, Dengel K, June CH, Champlin R, Kwak LW.
    Blood; 2022 Mar 03; 139(9):1289-1301. PubMed ID: 34521108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.